Skip to main content
Clinical Trials/ISRCTN54358864
ISRCTN54358864
Completed
未知

Miru multifocal contact lens performance and acceptance assessment

CooperVision (United States)0 sites27 target enrollmentJanuary 28, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
CooperVision (United States)
Enrollment
27
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 28, 2021
End Date
December 14, 2020
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
CooperVision (United States)

Eligibility Criteria

Inclusion Criteria

  • 1\. At least 40 years old
  • 2\. Have read and understood the Participant Information Sheet in English
  • 3\. Have read, signed and dated the Informed Consent
  • 4\. Best corrected visual acuity of at least 20/25 in each eye
  • 5\. Have normal eyes with the exception of the need for visual correction
  • 6\. Current multifocal soft contact lens wearer
  • 7\. Spectacle refraction:
  • Distance: Sphere: \-6\.00D to \+ 4\.00D
  • Astigmatism: 0\.00D to \-0\.75D
  • Near Addition: \+0\.75D to \+2\.50D

Exclusion Criteria

  • 1\. Currently wearing study contact lenses
  • 2\. Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear
  • 3\. Newly prescribed use of some systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator
  • 4\. Monocular participants (only one eye with functional vision) or participants fit with only one lens
  • 5\. Any moderate or severe ocular condition observed during the slit\-lamp examination at the enrolment visit
  • 6\. History of herpetic keratitis, ocular surgery or irregular cornea
  • 7\. Known pregnancy or lactation during the study period
  • 8\. Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator’s staff, or individuals living in the households of these individuals

Outcomes

Primary Outcomes

Not specified

Similar Trials